Company news

Immunome, Inc. news in 2023

Immunome, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Immunome to Acquire Antibody-Related Assets and Materials from Atreca

December 25, 2023

Immunome to Present at the Stifel 2023 Healthcare Conference

November 9, 2023

Immunome Reports Third Quarter 2023 Financial Results

November 8, 2023

Immunome Appoints Jean-Jacques Bienaimé to Board of Directors

November 7, 2023

Immunome Appoints Bob Lechleider, M.D., as Chief Medical Officer

October 18, 2023

Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies

October 2, 2023

Immunome Reports Second Quarter 2023 Financial Results

August 8, 2023

Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies

June 28, 2023

Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity

May 22, 2023

Immunome Reports First Quarter 2023 Financial Results

May 4, 2023

Immunome Reports Fourth Quarter and Full Year 2022 Financial Results

March 15, 2023

Immunome to Present at 13th Annual World ADC London Conference

March 8, 2023

Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board

February 7, 2023

AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets

January 5, 2023

Decks in 2023